Home › Funds › Saturn V Capital Management LP › RARE

Saturn V Capital Management LP position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

Saturn V Capital Management LP reported holding 758,771 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 1.67% of its reported portfolio and ranking #18 among its reported holdings. Saturn V Capital Management LP first reported this position in Q3 2026.

Latest position (Q3 2026)758.77K sh
Reported value held$11.40M
Portfolio Weight1.67%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's RARE position evolved

Saturn V Capital Management LP first disclosed a stake in RARE in Q3 2026 at 758,771 shares (US$11.4M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 758.77K $11.40M New

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 21 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$128.2M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has Saturn V Capital Management LP held RARE?

Saturn V Capital Management LP has disclosed RARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Saturn V Capital Management LP's current position in RARE?

As of Q3 2026, Saturn V Capital Management LP holds 758.77K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $11.40M, representing 1.67% of its reported portfolio and ranking #18.

Has Saturn V Capital Management LP been buying or selling RARE?

In the latest 13F filing (Q3 2026), Saturn V Capital Management LP newly opened its position in RARE.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.